Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2002
11/21/2002WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002WO2002092773A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002WO2002092762A2 Cytokine polypeptides
11/21/2002WO2002092759A2 Molecules for disease detection and treatment
11/21/2002WO2002092667A1 Biodegradable polyphosphates for controlled release of bioactive substances
11/21/2002WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002WO2002092540A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002WO2002092125A1 Compositions for use in treating ige-associated disorders
11/21/2002WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002WO2002092075A2 Therapeutic delivery of carbon monoxide
11/21/2002WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002WO2002092067A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/21/2002WO2002092064A2 Therapeutic method for inducing tolerance
11/21/2002WO2002092017A2 Human antipneumococcal antibodies from non-human animals
11/21/2002WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002WO2002078615A3 Antioxidant nitroxides and nitrones as therapeutic agents
11/21/2002WO2002074309A3 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
11/21/2002WO2002072034A3 Chronotherapeutic dosage forms
11/21/2002WO2002062343A3 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/21/2002WO2002062317A3 Bimodal dry powder formulation for inhalation
11/21/2002WO2002055514A3 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
11/21/2002WO2002049649A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
11/21/2002WO2002036171A9 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
11/21/2002WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002WO2001087350A3 Treatment of human papillomavirus (hpv)-infected cells
11/21/2002WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/21/2002US20020173661 Phosphodiesterase-4 (PDE4); thiazole-containing pyridine (N-oxide) compounds; 4-(2-(3,4-Bis(difluoromethoxy)phenyl)-2-(5-(2-(1-hydroxy-1 -methyl)ethyl)thiazolyl)ethyl)pyridine N-oxide for example
11/21/2002US20020173657 Method for the synthesis of quinoline derivatives
11/21/2002US20020173655 Thioether substituted imidazoquinoline or tetrahydroimdazoquinoline compounds induce the biosynthesis of cytokines such as interferon and useful for treating viral disease in an animal
11/21/2002US20020173648 Use in the treatment of PDE4 and TNF mediated diseases
11/21/2002US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002US20020173506 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
11/21/2002US20020173505 Antiserotonine agents; respiratory system disorders; antidepressants; eating disorders
11/21/2002US20020173500 Hypotensive agents; antiischemic agents
11/21/2002US20020173499 Estrogen replacement therapy
11/21/2002US20020173496 Formulation containing novel anti-inflammatory androstane derivative
11/21/2002US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002US20020173464 Modulation of pericyte proliferation
11/21/2002US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002US20020173449 O-superfamily conotoxin peptides
11/21/2002US20020173025 Human DNase I hyperactive variants
11/21/2002US20020172959 Compositions and methods relating to lung specific genes and proteins
11/21/2002US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002CA2451116A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002CA2447593A1 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002CA2447275A1 Therapeutic delivery of carbon monoxide
11/21/2002CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002CA2447114A1 Human antipneumococcal antibodies from non-human animals
11/21/2002CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002CA2447017A1 Moraxella(branhamella) catarrhalis antigens
11/21/2002CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002CA2446740A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002CA2446180A1 Cytokine polypeptides
11/21/2002CA2446108A1 Compositions for use in treating ige-associated disorders
11/21/2002CA2445366A1 Molecules for disease detection and treatment
11/21/2002CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002CA2443191A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/20/2002EP1258474A2 Alkylamide compounds
11/20/2002EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/20/2002EP1257822A1 Her-2 binding antagonists
11/20/2002EP1257653A2 Phosphodiesterase type 7b
11/20/2002EP1257646A2 Transporters and ion channels
11/20/2002EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002EP1257578A2 Transporters and ion channels
11/20/2002EP1257556A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
11/20/2002EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002EP1257554A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments
11/20/2002EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002EP1257546A1 Kinase inhibitors
11/20/2002EP1257539A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
11/20/2002EP1257537A1 Therapeutic morpholino-substituted compounds
11/20/2002EP1257295A2 Factor vii or viia-like molecules
11/20/2002EP1257270A1 A method for synthesizing leflunomide
11/20/2002EP1257262A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
11/20/2002EP1107732B1 Oral liquid mucoadhesive compositions
11/20/2002EP1098645B1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds)
11/20/2002EP1047688B1 Thiophene nitrone compounds
11/20/2002EP1007522B1 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, its preparation and therapeutic use
11/20/2002EP0984784B1 Anti-cancer products for treating cystic fibrosis
11/20/2002EP0912568B1 imidazopyridines
11/20/2002EP0833828B1 Rapamycin derivatives
11/20/2002EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
1 ... 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 ... 878